{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:00:04Z","timestamp":1759939204696,"version":"3.37.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,3,25]],"date-time":"2016-03-25T00:00:00Z","timestamp":1458864000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s13318-016-0332-7","type":"journal-article","created":{"date-parts":[[2016,3,25]],"date-time":"2016-03-25T03:23:19Z","timestamp":1458876199000},"page":"191-199","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The Ameliorated Pharmacokinetics of VP-16 in Wistar Rats: A Possible Role of P-Glycoprotein Inhibition by Pharmaceutical Excipients"],"prefix":"10.1007","volume":"42","author":[{"given":"Naseem","family":"Akhtar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul","family":"Ahad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohd Faiyaz","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman","family":"Allaham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushama","family":"Talegaonkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,25]]},"reference":[{"issue":"7","key":"332_CR1","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2165\/00003088-200443070-00002","volume":"43","author":"G Toffoli","year":"2004","unstructured":"Toffoli G, Corona G, Basso B, Boiocchi M. Pharmacokinetic optimisation of treatment with oral etoposide. Clin Pharmacokinet. 2004;43(7):441\u201366.","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"332_CR2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1158\/1078-0432.CCR-09-1321","volume":"16","author":"JS Lagas","year":"2010","unstructured":"Lagas JS, Fan L, Wagenaar E, Vlaming ML, van Tellingen O, Beijnen JH, et al. P-glycoprotein (P-gp\/Abcb1), Abcc2, and Abcc3 determine the pharmacokinetics of etoposide. Clin Cancer Res. 2010;16(1):130\u201340.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"332_CR3","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1166\/jbn.2013.1613","volume":"9","author":"N Akhtar","year":"2013","unstructured":"Akhtar N, Talegaonkar S, Khar RK, Jaggi M. Self-nanoemulsifying lipid carrier system for enhancement of oral bioavailability of etoposide by P-glycoprotein modulation: in vitro cell line and in vivo pharmacokinetic investigation. J Biomed Nanotechnol. 2013;9(7):1216\u201329.","journal-title":"J Biomed Nanotechnol"},{"issue":"21\u201322","key":"332_CR4","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.drudis.2009.07.010","volume":"14","author":"T Bansal","year":"2009","unstructured":"Bansal T, Akhtar N, Jaggi M, Khar RK, Talegaonkar S. Novel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulation. Drug Discov Today. 2009;14(21\u201322):1067\u201374.","journal-title":"Drug Discov Today"},{"issue":"4","key":"332_CR5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1043-6618(03)00158-0","volume":"48","author":"MV Varma","year":"2003","unstructured":"Varma MV, Ashokraj Y, Dey CS, Panchagnula R. P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement. Pharmacol Res. 2003;48(4):347\u201359.","journal-title":"Pharmacol Res"},{"issue":"1\u20132","key":"332_CR6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2008.11.021","volume":"370","author":"MF Wempe","year":"2009","unstructured":"Wempe MF, Wright C, Little JL, Lightner JW, Large SE, Caflisch GB, et al. Inhibiting efflux with novel non-ionic surfactants: rational design based on vitamin E TPGS. Int J Pharm. 2009;370(1\u20132):93\u2013102.","journal-title":"Int J Pharm"},{"issue":"6","key":"332_CR7","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.addr.2007.09.010","volume":"60","author":"ML Chen","year":"2008","unstructured":"Chen ML. Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective. Adv Drug Deliv Rev. 2008;60(6):768\u201377.","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"332_CR8","first-page":"1195","volume":"32","author":"H Riehm","year":"1972","unstructured":"Riehm H, Biedler JL. Potentiation of drug effect by Tween 80 in Chinese hamster cells resistant to actinomycin D and daunomycin. Cancer Res. 1972;32(6):1195\u2013200.","journal-title":"Cancer Res"},{"issue":"1","key":"332_CR9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/bjc.1992.217","volume":"66","author":"DM Woodcock","year":"1992","unstructured":"Woodcock DM, Linsenmeyer ME, Chojnowski G, Kriegler AB, Nink V, Webster LK, et al. Reversal of multidrug resistance by surfactants. Br J Cancer. 1992;66(1):62\u20138.","journal-title":"Br J Cancer"},{"issue":"4","key":"332_CR10","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1517\/13543776.2011.561784","volume":"21","author":"N Akhtar","year":"2011","unstructured":"Akhtar N, Ahad A, Khar RK, Jaggi M, Aqil M, Iqbal Z, et al. The emerging role of P-glycoprotein inhibitors in drug delivery: a patent review. Expert Opin Ther Pat. 2011;21(4):561\u201376.","journal-title":"Expert Opin Ther Pat"},{"issue":"2","key":"332_CR11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/jps.20780","volume":"96","author":"PP Constantinides","year":"2007","unstructured":"Constantinides PP, Wasan KM. Lipid formulation strategies for enhancing intestinal transport and absorption of P-glycoprotein (P-gp) substrate drugs: in vitro\/in vivo case studies. J Pharm Sci. 2007;96(2):235\u201348.","journal-title":"J Pharm Sci"},{"issue":"1","key":"332_CR12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijpharm.2004.03.001","volume":"278","author":"G Cornaire","year":"2004","unstructured":"Cornaire G, Woodley J, Hermann P, Cloarec A, Arellano C, Houin G. Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. Int J Pharm. 2004;278(1):119\u201331.","journal-title":"Int J Pharm"},{"issue":"Suppl","key":"332_CR13","first-page":"37","volume":"12","author":"A Parsa","year":"2013","unstructured":"Parsa A, Saadati R, Abbasian Z, Azad Aramaki S, Dadashzadeh S. Enhanced permeability of etoposide across everted sacs of rat small intestine by vitamin E-TPGS. Iran. J Pharm Res. 2013;12(Suppl):37\u201346.","journal-title":"J Pharm Res"},{"issue":"4\u20135","key":"332_CR14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0928-0987(02)00055-6","volume":"16","author":"BD Rege","year":"2002","unstructured":"Rege BD, Kao JP, Polli JE. Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. Eur J Pharm Sci. 2002;16(4\u20135):237\u201346.","journal-title":"Eur J Pharm Sci"},{"issue":"5","key":"332_CR15","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0009-9236(03)00059-6","volume":"73","author":"Y Tayrouz","year":"2003","unstructured":"Tayrouz Y, Ding R, Burhenne J, Riedel KD, Weiss J, Hoppe-Tichy T, et al. Pharmacokinetic and pharmaceutic interaction between digoxin and Cremophor RH40. Clin Pharmacol Ther. 2003;73(5):397\u2013405.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"332_CR16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0168-3659(03)00163-9","volume":"90","author":"YL Lo","year":"2003","unstructured":"Lo YL. Relationships between the hydrophilic-lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines. J Control Releas. 2003;90(1):37\u201348.","journal-title":"J Control Releas"},{"issue":"1\u20132","key":"332_CR17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijpharm.2006.02.018","volume":"315","author":"RD Dabholkar","year":"2006","unstructured":"Dabholkar RD, Sawant RM, Mongayt DA, Devarajan PV, Torchilin VP. Polyethylene glycol-phosphatidylethanolamine conjugate (PEG-PE)-based mixed micelles: some properties, loading with paclitaxel, and modulation of P-glycoprotein-mediated efflux. Int J Pharm. 2006;315(1\u20132):148\u201357.","journal-title":"Int J Pharm"},{"issue":"5","key":"332_CR18","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ejps.2009.05.001","volume":"37","author":"S Zhu","year":"2009","unstructured":"Zhu S, Huang R, Hong M, Jiang Y, Hu Z, Liu C, et al. Effects of polyoxyethylene (40) stearate on the activity of P-glycoprotein and cytochrome P450. Eur J Pharm Sci. 2009;37(5):573\u201380.","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"332_CR19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jsps.2012.01.005","volume":"21","author":"N Akhtar","year":"2013","unstructured":"Akhtar N, Talegaonkar S, Khar RK, Jaggi M. A validated stability-indicating LC method for estimation of etoposide in bulk and optimized self-nano emulsifying formulation: kinetics and stability effects. Saudi Pharm J. 2013;21(1):103\u201311.","journal-title":"Saudi Pharm J"},{"key":"332_CR20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jddst.2015.05.003","volume":"28","author":"N Akhtar","year":"2015","unstructured":"Akhtar N, Talegaonkar S, Ahad A, Khar RK. Potential of a novel self nanoemulsifying carrier system to overcome P-glycoprotein mediated efflux of etoposide: In vitro and ex vivo investigations. J Drug Deliv Sci Technol. 2015;28:18\u201327","journal-title":"J Drug Deliv Sci Technol"},{"issue":"3","key":"332_CR21","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"S Reagan-Shaw","year":"2008","unstructured":"Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. Faseb J. 2008;22(3):659\u201361.","journal-title":"Faseb J"},{"issue":"4","key":"332_CR22","first-page":"219","volume":"50","author":"EJ Freireich","year":"1966","unstructured":"Freireich EJ, Gehan EA, Rall DP, Schmidt LH, Skipper HE. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother Rep. 1966;50(4):219\u201344.","journal-title":"Cancer Chemother Rep"},{"issue":"1\u20133","key":"332_CR23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0169-409X(00)00126-5","volume":"46","author":"VJ Wacher","year":"2001","unstructured":"Wacher VJ, Salphati L, Benet LZ. Active secretion and enterocytic drug metabolism barriers to drug absorption. Adv Drug Deliv Rev. 2001;46(1\u20133):89\u2013102.","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"332_CR24","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.3109\/03639045.2011.582874","volume":"37","author":"Y Shen","year":"2011","unstructured":"Shen Y, Lu Y, Jv M, Hu J, Li Q, Tu J. Enhancing effect of Labrasol on the intestinal absorption of ganciclovir in rats. Drug Dev Ind Pharm. 2011;37(12):1415\u201321.","journal-title":"Drug Dev Ind Pharm"},{"issue":"7","key":"332_CR25","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1248\/bpb.30.1301","volume":"30","author":"Y Lin","year":"2007","unstructured":"Lin Y, Shen Q, Katsumi H, Okada N, Fujita T, Jiang X, et al. Effects of Labrasol and other pharmaceutical excipients on the intestinal transport and absorption of rhodamine123, a P-glycoprotein substrate, in rats. Biol Pharm Bull. 2007;30(7):1301\u20137.","journal-title":"Biol Pharm Bull"},{"issue":"2","key":"332_CR26","first-page":"143","volume":"56","author":"LH Reddy","year":"2006","unstructured":"Reddy LH, Sharma RK, Murthy RR. Enhanced delivery of etoposide to Dalton\u2019s lymphoma in mice through polysorbate 20 micelles. Acta Pharm. 2006;56(2):143\u201355.","journal-title":"Acta Pharm"},{"issue":"5","key":"332_CR27","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ejps.2005.01.001","volume":"24","author":"X Sha","year":"2005","unstructured":"Sha X, Yan G, Wu Y, Li J, Fang X. Effect of self-microemulsifying drug delivery systems containing Labrasol on tight junctions in Caco-2 cells. Eur J Pharm Sci. 2005;24(5):477\u201386.","journal-title":"Eur J Pharm Sci"}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-016-0332-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13318-016-0332-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-016-0332-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-016-0332-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T11:44:40Z","timestamp":1559475880000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13318-016-0332-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,25]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["332"],"URL":"https:\/\/doi.org\/10.1007\/s13318-016-0332-7","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"type":"print","value":"0378-7966"},{"type":"electronic","value":"2107-0180"}],"subject":[],"published":{"date-parts":[[2016,3,25]]}}}